Globe Life (NYSE:GL - Get Free Report) is expected to be announcing its Q2 2025 earnings results after the market closes on Wednesday, July 23rd. Analysts expect Globe Life to post earnings of $3.27 per share and revenue of $1.50 billion for the quarter. Globe Life has set its FY 2025 guidance at 13.450-14.050 EPS.
Globe Life (NYSE:GL - Get Free Report) last announced its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 earnings per share for the quarter, missing the consensus estimate of $3.24 by ($0.17). Globe Life had a net margin of 18.33% and a return on equity of 21.44%. The firm had revenue of $1.48 billion during the quarter, compared to analyst estimates of $1.49 billion. During the same quarter last year, the company earned $2.78 EPS. The company's quarterly revenue was up 4.5% compared to the same quarter last year. On average, analysts expect Globe Life to post $14 EPS for the current fiscal year and $15 EPS for the next fiscal year.
Globe Life Trading Up 0.5%
Shares of NYSE GL traded up $0.60 during mid-day trading on Friday, hitting $122.20. 591,766 shares of the company traded hands, compared to its average volume of 700,838. Globe Life has a 1 year low of $86.10 and a 1 year high of $133.76. The stock has a market capitalization of $10.09 billion, a price-to-earnings ratio of 9.94 and a beta of 0.56. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.43. The business has a 50 day moving average of $120.87 and a two-hundred day moving average of $121.51.
Globe Life Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Thursday, July 3rd will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.88%. The ex-dividend date is Thursday, July 3rd. Globe Life's dividend payout ratio is 8.79%.
Analyst Ratings Changes
Several equities research analysts have recently commented on GL shares. Wells Fargo & Company lifted their target price on Globe Life from $139.00 to $144.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. JPMorgan Chase & Co. raised their price target on Globe Life from $145.00 to $160.00 and gave the stock an "overweight" rating in a research report on Tuesday, July 8th. Piper Sandler reduced their price target on Globe Life from $152.00 to $147.00 and set an "overweight" rating on the stock in a research report on Friday, May 2nd. Morgan Stanley set a $127.00 target price on Globe Life and gave the stock an "equal weight" rating in a report on Monday, July 14th. Finally, Wall Street Zen upgraded Globe Life from a "hold" rating to a "buy" rating in a report on Friday, May 16th. Three equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $143.82.
Get Our Latest Research Report on Globe Life
Insiders Place Their Bets
In other news, CEO Frank M. Svoboda sold 6,019 shares of the stock in a transaction on Tuesday, May 20th. The shares were sold at an average price of $122.51, for a total value of $737,387.69. Following the completion of the sale, the chief executive officer directly owned 31,298 shares of the company's stock, valued at $3,834,317.98. This represents a 16.13% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.51% of the stock is currently owned by company insiders.
Institutional Investors Weigh In On Globe Life
Institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Globe Life by 6.9% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 9,391 shares of the company's stock valued at $1,237,000 after buying an additional 607 shares during the period. Focus Partners Wealth raised its stake in Globe Life by 8.3% during the first quarter. Focus Partners Wealth now owns 8,559 shares of the company's stock worth $1,127,000 after purchasing an additional 656 shares during the period. Acadian Asset Management LLC purchased a new position in Globe Life during the first quarter worth about $322,000. Empowered Funds LLC purchased a new stake in shares of Globe Life in the 1st quarter valued at approximately $428,000. Finally, NewEdge Advisors LLC raised its stake in shares of Globe Life by 368.1% in the 1st quarter. NewEdge Advisors LLC now owns 6,806 shares of the company's stock valued at $897,000 after acquiring an additional 5,352 shares during the period. 81.61% of the stock is currently owned by institutional investors and hedge funds.
Globe Life Company Profile
(
Get Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Featured Stories
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
